Evaluation of efficacy of interferon inducer in treatment of the recurrent acute respiratory viral infections in children Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012
Efficacy of short-term high dose predonisolone therapy in acute exacerbation of bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 71s Year: 2001
Short versus prolonged low dose steroid therapy early in the course of acute lung injury Source: Eur Respir J 2004; 24: Suppl. 48, 263s Year: 2004
Effect of inhaled SNG001 (interferon-beta 1a) on sputum and blood antiviral biomarkers following a respiratory virus infection in asthmatic subjects Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013
High dose short course of inhaled corticosteroid administration may prevent home oxygen therapy in neonatal chronic lung disease Source: Eur Respir J 2003; 22: Suppl. 45, 140s Year: 2003
The effects of oral corticosteroid treatment (OCS) on sequential lung function tests in a cohort of patients with acute hypersensitivity pneumonitis (AHP) Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children Year: 2020
Short-term survival of acute respiratory distress syndrome patients due to influenza virus infection alone: a cohort study Source: ERJ Open Res, 6 (4) 00587-2020; 10.1183/23120541.00587-2020 Year: 2020
Development of inhalation therapy for prevention and treatment of acute lung injury Source: Annual Congress 2010 - Acute respiratory failure Year: 2010
Analysis of serum cytokine levels before and after isoprinosine treatment in children with acute viral respiratory infections Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors Year: 2010
Low-dose corticosteroid use and mortality in severe community-acquired pneumonia patients Source: Eur Respir J 2015; 45: 463-472 Year: 2015
Evidence of biological efficacy for prolonged glucocorticoid treatment in patients with unresolving ARDS Source: Eur Respir J 2003; 22: 57S-64S Year: 2003
Eosinopenia in COPD patients with severe acute respiratory virus 2 (Sars-CoV-2) infection as a potential fatal outcome predictor Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021
Role of inhaled corticosteroids on recurrent bronchial infection by potentially pathogenic bacteria in patients with COPD Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020
Early corticosteroid in influenza pneumonia related acute respiratory distress syndrome treated with extracorporeal membrane oxygenation Source: International Congress 2018 – Preclinical and clinical studies of critical illness Year: 2018
Assessing the incidence pattern of pneumonia among COPD patients with or without exposure to inhaled steroids Source: Annual Congress 2007 - Epidemiology of COPD Year: 2007
Airway administration of therapeutic antibody (tAb) confers higher protection than parenteral administration in a murine model of acute lung infection Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies Year: 2018
New nebulized treatment options for bronchial infection in lung transplant Source: Virtual Congress 2020 – Clinical management of lung transplant recipients Year: 2020
Successful treatment of severe respiratory papillomatosis with intravenous cidofovir and interferon α-2b Source: Eur Respir J 2002; 20: Suppl. 38, 157s Year: 2002
IV salbutamol as alternative treatment to intubation in RSV epidemic acute infantile bronchiolitis Source: Annual Congress 2003 - New perspectives in bronchiolitis Year: 2003
Recurrent eosinophilic pneumonia in an asthmatic patient treated with sequential montelukast/zafirlukast after corticosteroid withdrawal Source: Eur Respir J 2002; 20: Suppl. 38, 52s Year: 2002